CTSA K12 Program at Virginia Commonwealth University

弗吉尼亚联邦大学 CTSA K12 项目

基本信息

项目摘要

The COVID-19 pandemic highlighted the critical importance of translational research to eradicate human disease, tackle emerging public health threats and promote health, especially in hard-to-reach communities that face health disparities. To take on these challenges, we need a diverse, well-resourced, and well-trained research workforce, as highlighted by the NIH Physician-Scientist Workforce report. 1 The VCU Wright Regional Center for Clinical and Translational Science (Wright Regional CCTS) serves a region in Central and Eastern Virginia and North Carolina that includes both rural and urban underserved communities and has vast experience serving a diverse community of patients who often face health disparities. The nature of our environment has driven the development of a research workforce that is prepared to meet the challenge of engaging and serving diverse patients. The Wright Regional CCTS serves as the hub for providing the translational research infrastructure for the training and career development of scholars through their professional life cycle. In addition, The Wright Center CCTS has a $32 million endowment with which we have established the first Wright Faculty Scholars in Health Disparities program. This program supports early career faculty from diverse backgrounds who are committed to better understanding the drivers and developing solutions to health inequities in our communities. Our existing partner institutions bring experience training the workforce across the translational spectrum with an emphasis on community engaged research (Eastern Virginia Medical School (EVMS)), informatics (Old Dominion University (ODU)) and mentorship (Virginia State University (VSU), an HBCU). Training scholars to translate research observations to clinical application in our unique communities is a priority for the proposed K12 Training Program. Our program will continue its commitment to providing early career faculty/late-stage postdoctoral fellows with a comprehensive “blueprint” for transitioning to research independence. We will recruit scholars from a pool of early career scientists who are diverse in both research discipline and demographics. Through integration with our UM1 and RC2 awards, K12 scholars will be exposed to an innovative and comprehensive program that supports 75% committed time to scholar specific domain expertise but also provides a combination of didactic, virtual, and experiential training in fundamental characteristics of the translational scientist. We will achieve our goals through the following specific aims: Aim 1: Prepare early career translational researchers for research independence through comprehensive, innovative, and individualized training in translational science. K12 scholars will be positioned to translate preclinical, clinical, and community-based research to improving health of all communities. Aim 2: Serve as an institutional resource for research career development and facilitate the creation of a diverse community of clinical and translational researchers through both internal and external partnerships.
COVID-19大流行强调了转化研究对辐射人类的至关重要的重要性 疾病,应对新兴的公共卫生威胁并促进健康,尤其是在难以到达的社区中 面对健康差异。要应对这些挑战,我们需要潜水员,资源丰富且训练有素的 NIH医师科学家劳动力报告强调了研究人员。 1 VCU Wright地区 临床与转化科学中心(Wright Regional CCTS)为中部和东部地区的一个地区服务 弗吉尼亚州和北卡罗来纳州包括粗糙和城市服务不足的社区,并拥有丰富的经验 服务经常面临健康分配的患者多样性社区。我们环境的本质 驱动了准备应对参与和服务的挑战的研究劳动力的发展 多样化的患者。赖特地区CCTs是提供转化研究的枢纽 此外,通过其职业生命周期进行培训和职业发展的基础设施。 Wright Center CCTS拥有3200万美元的捐赠,我们建立了第一家赖特教职员工 健康差异计划的学者。该计划支持潜水员背景的早期职业教师 谁致力于更好地理解驱动因素并为我们的健康不平等而开发解决方案 社区。我们现有的合作伙伴机构带来经验培训翻译的劳动力 频谱重点是社区参与研究(东弗吉尼亚医学院(EVMS)), 信息信息(ODU大学(ODU))和Mentalship(Virginia State University(VSU),HBCU)。 培训学者将研究观察结果转化为我们独特的临床应用 社区是拟议的K12培训计划的优先事项。我们的计划将继续其承诺 提供早期职业教师/晚期博士后研究员,并提供全面的“蓝图” 研究独立性。我们将从两者的潜水员的早期职业科学家招募学者 研究学科和人口统计学。通过与我们的UM1和RC2奖的集成,K12学者将 接触一项创新且全面的计划,该计划支持75%的授权时间 特定的领域专业知识,但还提供了教学,虚拟和专家培训的结合 转化科学家的基本特征。 我们将通过以下特定目标来实现我们的目标: 目标1:通过综合,准备早期职业翻译研究人员的研究独立性 转化科学领域的创新和个性化培训。 K12学者将定位用于翻译 临床前,临床和基于社区的研究,以改善所有社区的健康。 目标2:作为研究职业发展的机构资源,并促进潜水员的创建 通过内部和外部合作伙伴关系,临床和翻译研究人员社区。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SERGE PATRICK NANASINKAM其他文献

SERGE PATRICK NANASINKAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SERGE PATRICK NANASINKAM', 18)}}的其他基金

Project 1: Lung Cancer
项目一:肺癌
  • 批准号:
    10493289
  • 财政年份:
    2021
  • 资助金额:
    $ 74.95万
  • 项目类别:
Project 1: Lung Cancer
项目一:肺癌
  • 批准号:
    10290161
  • 财政年份:
    2021
  • 资助金额:
    $ 74.95万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    10409658
  • 财政年份:
    2018
  • 资助金额:
    $ 74.95万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    9913602
  • 财政年份:
    2018
  • 资助金额:
    $ 74.95万
  • 项目类别:
MicroRNA Expression in Lung Cancer Development and Progression
肺癌发生和进展中的 MicroRNA 表达
  • 批准号:
    8021770
  • 财政年份:
    2010
  • 资助金额:
    $ 74.95万
  • 项目类别:
MicroRNA Expression in Lung Cancer Development and Progression
肺癌发生和进展中的 MicroRNA 表达
  • 批准号:
    7873350
  • 财政年份:
    2010
  • 资助金额:
    $ 74.95万
  • 项目类别:
Integration of transcriptosome and microRNome in Understanding COPD Phenotypes
转录体和 microRNome 的整合在理解 COPD 表型中的作用
  • 批准号:
    7690864
  • 财政年份:
    2008
  • 资助金额:
    $ 74.95万
  • 项目类别:
Regulation of Prostacyclin in Pulmonary Hypertension
前列环素在肺动脉高压中的调节
  • 批准号:
    6933068
  • 财政年份:
    2004
  • 资助金额:
    $ 74.95万
  • 项目类别:
Regulation of Prostacyclin in Pulmonary Hypertension
前列环素在肺动脉高压中的调节
  • 批准号:
    6817114
  • 财政年份:
    2004
  • 资助金额:
    $ 74.95万
  • 项目类别:
Regulation of Prostacyclin in Pulmonary Hypertension
前列环素在肺动脉高压中的调节
  • 批准号:
    7480211
  • 财政年份:
    2004
  • 资助金额:
    $ 74.95万
  • 项目类别:

相似海外基金

Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
A Brief Intervention to Enhance Supportive Parenting and Treatment Engagement Among Families Waiting for Trauma-Focused Services
一项简短的干预措施,以加强等待创伤重点服务的家庭的支持性养育和治疗参与
  • 批准号:
    10644434
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
Disparities in Quality Healthcare Among Childhood Cancer Survivors: Role of Medicaid
儿童癌症幸存者的医疗质量差异:医疗补助的作用
  • 批准号:
    10722895
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
Improving access to opioid use disorder treatment among marginalized patients with a tailored telehealth intervention
通过量身定制的远程医疗干预措施,改善边缘化患者获得阿片类药物使用障碍治疗的机会
  • 批准号:
    10739650
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
Virtual Care Coordination in VA Primary Care-Mental Health Integration
退伍军人事务部初级保健-心理健康一体化中的虚拟护理协调
  • 批准号:
    10639607
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了